J Gynecol Oncol.  2011 Mar;22(1):57-60. 10.3802/jgo.2011.22.1.57.

Early port-site metastasis during neoadjuvant chemotherapy in advanced stage ovarian cancer: report of two cases

Affiliations
  • 1Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine, Ankara, Turkey. yesukur@yahoo.com
  • 2Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey.

Abstract

Port-site metastases in gynecological malignancies subsequent to laparoscopy have been reported with an incidence of 1.1-16%. These metastases tend to be disappearing after primary debulking surgery and subsequent primary chemotherapy. Local resection, chemotherapy and/or radiotherapy have been defined in the management of these metastases with enhanced clinical success. However, in extremely rare cases these metastases were also defined very early during neoadjuvant chemotherapy. Herein, we present two ovarian cancer cases which are clinically diagnosed with port site metastasis during neoadjuvant chemotherapy following diagnostic laparoscopy. Although neoadjuvant chemotherapy is sometimes needed in cases of fully advanced ovarian cancers, port-site metastasis may be encountered during neoadjuvant chemotherapy. The possible poor prognosis of these patients, especially those who have ascites, should make us careful in performing diagnostic laparoscopy with preventive measures for port-site metastasis and to start the chemotherapy immediately.

Keyword

Early port-site metastasis; Laparoscopy; Neoadjuvant chemotherapy; Ovarian cancer

MeSH Terms

Ascites
Humans
Incidence
Laparoscopy
Neoplasm Metastasis
Ovarian Neoplasms
Prognosis
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr